Cartesian Growth Corp II (RENEF)

Cartesian Growth Corp II arrived as a blank-check vehicle in 2022, backed by Cartesian Capital Group, a private-equity firm founded by Peter Yu. The company held the standard SPAC formula: raise capital from public investors, find a private business willing to go public via acquisition, merge, and hand the combined entity a public listing.

The maths were straightforward at inception. Cartesian Growth Corp II raised $236.9 million in its trust account — the capital to be deployed into a business combination. But maths on paper and maths in execution rarely align in the SPAC world.

The problem in plain terms

Blank-check companies operate against a ticking clock. Regulators impose deadlines: the SPAC must find and close a business combination within a stated period, typically 24 or 36 months from IPO. If the deadline approaches without a deal, the SPAC can extend the deadline once, sometimes twice, but each extension requires shareholder approval and triggers a cash drain. Shareholders who doubt a deal will close can redeem their shares for their pro-rata slice of the trust account’s cash before the final deadline. Redemptions erode the pool available to actually do the deal, sometimes leaving too little capital to make an acquisition attractive.

Cartesian Growth faced successive redemption waves as its deadline extensions piled up. By November 2025 — after three charter extensions — the trust account was down to approximately $37.75 million, a collapse from the original $236.9 million. That kind of erosion suggests the market lost confidence that management would find an acceptable deal.

Delisting and the shifting landscape

In May 2025, Nasdaq moved to delist Cartesian Growth under Rule IM-5101-2 because no business combination had closed within 36 months of the IPO registration’s effectiveness. The company’s shares migrated to the OTC Pink Limited Market, a far less visible venue with lower trading volumes and less institutional attention. For any investor holding shares, this was a catastrophic event: liquidity evaporated, the stock became difficult to trade, and price discovery became sporadic.

This is the terminal risk for any SPAC: failing to close a deal by the deadline and watching the stock become worthless or illiquid. It is not always a fraud; it is often simply a failure of execution — management underestimating how hard it is to find and negotiate a good business, or how fickle the public markets can be toward SPACs in particular.

The path forward, if any

Cartesian still has until August 5, 2026, to close a business combination before the extended deadline expires. That leaves a narrow window, though in the SPAC world, deals have been negotiated and closed in weeks when there is genuine momentum. The remaining capital and the track record of Cartesian Capital Group suggest that if management found a willing target, it could theoretically execute.

But the structural headwinds are severe. The SPAC’s collapse from $236.9 million to $37.75 million means any acquisition target would walk into a public company with minimal cash reserves, which is unattractive. The company’s presence on the OTC market (rather than a major exchange) makes it less appealing as a merger partner, because the combined entity would inherit the OTC listing and associated illiquidity. Cartesian Capital Group’s reputation, whatever capital or operational support it might offer, cannot fully compensate for that.

The moat is borrowed time

SPACs have no moat. They have a pool of capital and a deadline. If they find a business and execute the merger, they are succeeded by an operating company with whatever advantages (or disadvantages) that business actually possesses. If they miss the deadline or fail to close an attractive deal, they are worth only their net cash value, which in Cartesian’s case has eroded to almost nothing.

Cartesian Growth Corp II is an instructive case in how SPAC arbitrage works in reality: an optimistic sponsor, a pool of retail and institutional capital willing to back it, and a series of extensions and redemptions that slowly erode the pool until the company is barely viable. The company is not operating a business; it is racing against time to acquire one before its window closes and its equity becomes worthless.

Where the filings live

The SEC record for Cartesian Growth Corp II is at CIK 0001889112. The most recent 10-K filings contain the charter amendments, the redemption mechanics, and the balance sheet. These documents are dense but revealing: they show explicitly how much capital the SPAC has lost to redemptions at each extension vote, and what leverage remains for management to negotiate any deal. Any investor considering even speculative exposure to Cartesian should read the latest 10-K and the company’s investor presentation (if any) to understand the precise countdown and the terms of any proposed transaction.